ETA receptors mediate vasoconstriction, whereas ETB receptors clear endothelin-1 in the splanchnic and renal circulation of healthy men
- PMID: 12546636
- DOI: 10.1042/CS20020192
ETA receptors mediate vasoconstriction, whereas ETB receptors clear endothelin-1 in the splanchnic and renal circulation of healthy men
Abstract
The contribution of the endothelin (ET) receptors ET(A) and ET(B) to basal vascular tone and ET-1-induced vasoconstriction in the renal and splanchnic vasculature was investigated in six healthy humans. ET-1 was infused alone and in combination with the selective ET(A) receptor antagonist BQ123 or the selective ET(B) receptor antagonist BQ788 on three different occasions. BQ123 did not affect basal arterial blood pressure, splanchnic vascular resistance (SplVR) or renal vascular resistance (RVR), but inhibited the increase in vascular resistance induced by ET-1 [64+/-18 versus -1+/-7% in SplVR ( P <0.05); 36+/-6 versus 12+/-3% in RVR ( P <0.0001)]. BQ788 increased basal SplVR and RVR [38+/-16% ( P =0.01) and 21+/-5% ( P <0.0001) respectively], and potentiated the ET-1-induced vasoconstriction. Plasma ET-1 increased more after ET(B) blockade than under control conditions or after ET(A) blockade. These findings suggest that the ET(A) receptor mediates the splanchnic and renal vasoconstriction induced by ET-1 in healthy humans. The ET(B) receptor seems to function as a clearance receptor and may modulate vascular tone by altering the plasma concentration of ET-1.
Similar articles
-
Endothelin receptors mediating vasoconstriction in rat pressurized small arteries.Can J Physiol Pharmacol. 1996 Aug;74(8):934-9. Can J Physiol Pharmacol. 1996. PMID: 8960383
-
Systemic ETA receptor antagonism with BQ-123 blocks ET-1 induced forearm vasoconstriction and decreases peripheral vascular resistance in healthy men.Br J Pharmacol. 2001 Oct;134(3):648-54. doi: 10.1038/sj.bjp.0704304. Br J Pharmacol. 2001. PMID: 11588120 Free PMC article. Clinical Trial.
-
Insulin sensitivity and big ET-1 conversion to ET-1 after ETA- or ETB-receptor blockade in humans.J Appl Physiol (1985). 2002 Dec;93(6):2112-21. doi: 10.1152/japplphysiol.00477.2002. Epub 2002 Sep 6. J Appl Physiol (1985). 2002. PMID: 12391119 Clinical Trial.
-
Endothelin in the pulmonary circulation with special reference to hypoxic pulmonary vasoconstriction.Scand Cardiovasc J Suppl. 1997;46:1-40. Scand Cardiovasc J Suppl. 1997. PMID: 9265559 Review.
-
Endothelin receptor antagonists and their developing role in cardiovascular therapeutics.Can J Cardiol. 2000 Jul;16(7):903-10. Can J Cardiol. 2000. PMID: 10934309 Review.
Cited by
-
Endothelin receptors and their antagonists.Semin Nephrol. 2015 Mar;35(2):125-36. doi: 10.1016/j.semnephrol.2015.02.002. Semin Nephrol. 2015. PMID: 25966344 Free PMC article. Review.
-
Endothelin-2, the forgotten isoform: emerging role in the cardiovascular system, ovarian development, immunology and cancer.Br J Pharmacol. 2013 Jan;168(2):283-95. doi: 10.1111/j.1476-5381.2011.01786.x. Br J Pharmacol. 2013. PMID: 22118774 Free PMC article. Review.
-
Bosentan effects in hypoxic pulmonary vasoconstriction: Preliminary study in subjects with or without high altitude pulmonary edema-history.Pulm Circ. 2012 Jan-Mar;2(1):28-33. doi: 10.4103/2045-8932.94824. Pulm Circ. 2012. PMID: 22558517 Free PMC article.
-
Glytan decreases portal pressure via mesentery vasoconstriction in portal hypertensive rats.World J Gastroenterol. 2014 Nov 28;20(44):16674-82. doi: 10.3748/wjg.v20.i44.16674. World J Gastroenterol. 2014. PMID: 25469036 Free PMC article.
-
Endothelin, astrocytes and glaucoma.Exp Eye Res. 2011 Aug;93(2):170-7. doi: 10.1016/j.exer.2010.09.006. Epub 2010 Sep 16. Exp Eye Res. 2011. PMID: 20849847 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources